Ciprofloxacin 250mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Ciprofloxacin hydrochloride

Available from:

Almus Pharmaceuticals Ltd

ATC code:

J01MA02

INN (International Name):

Ciprofloxacin hydrochloride

Dosage:

250mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 05011200; GTIN: 05060057400593

Patient Information leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER
CIPROFLOXACIN 100 MG TABLETS
CIPROFLOXACIN 250 MG TABLETS
CIPROFLOXACIN 500 MG TABLETS
CIPROFLOXACIN 750 MG TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING
THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMA-
TION FOR YOU.
•
Keep this leaflet. You may need to read again.
•
If you have any further questions, ask your doctor or
pharmacist.
•
This medicine has been prescribed for you only. Do
not pass it on to others. It may harm them, even if
their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1. What Ciprofloxacin tablets are and what they are
used for
2. What you need to know before you take
Ciprofloxacin tablets
3. How to take Ciprofloxacin tablets
4. Possible side effects
5. How to store Ciprofloxacin tablets
6. Contents of the pack and other information
1. WHAT CIPROFLOXACIN TABLETS ARE AND
WHAT THEY ARE USED FOR
The active substance is Ciprofloxacin. Ciprofloxacin is an
antibiotic belonging to the fluoroquinolone family.
Ciprofloxacin works by killing bacteria that cause infec-
tions. It only works with specific strains of bacteria.
_ADULTS_
Ciprofloxacin is used in adults to treat the following
bacterial infections:
•
respiratory tract infections
•
long lasting or recurring ear or sinus infections
•
urinary tract infections
•
genital tract infections in men and women
•
gastro-intestinal tract infections and intra-abdominal
infections
•
skin and soft tissue infections
•
bone and joint infections
•
to prevent infections due to the bacterium _Neisseria_
_meningitidis_
•
anthrax inhalation exposure
Ciprofloxacin may be used in the management of patients
with low white blood cell counts (neutropenia) who have
a fever that is suspected to be due to a bacterial infection.
If you have a severe infection or one that is caused by more
than one type of bacterium, you ma

Summary of Product characteristics

1
SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ciprofloxacin 250 mg, film coated tablets.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each
tablet
contains
291.0mg
ciprofloxacin
hydrochloride
equivalent
to
250mg
ciprofloxacin (INN).
For excipients see 6.1
3
PHARMACEUTICAL FORM
Film coated tablets.
Off-white, round, biconvex, film coated tablets with CP/250 on one
side and
on the
other.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Ciprofloxacin is indicated for the treatment of the following
infections caused by
sensitive bacteria:
_ _
_ADULTS:_
_ _
_Respiratory tract infections_: e.g. lobar and bronchopneumonia, acute
and chronic
bronchitis,
acute
exacerbation
of
cystic
fibrosis,
bronchiectasis,
empyema.
Ciprofloxacin
is
not
recommended
as
first-line
therapy
for
the
treatment
of
pneumococcal pneumonia. Ciprofloxacin may be used for treating
Gram-negative
pneumonia.
_ _
_Ear, nose and throat infections_: e.g. mastoiditis, otitis media and
sinusitis, especially
if due to Gram-negative bacteria (including_ Pseudomonas _spp.)_._
Ciprofloxacin is not
recommended for the treatment of acute tonsillitis.
_ _
_Eye infections:_ e.g. bacterial conjunctivitis.
_ _
2
_Urinary _
_tract _
_infections: _
e.g.
uncomplicated
and
complicated
urethritis,
cystitis,
pyelonephritis, prostatitis, epididymitis.
_ _
_Skin and soft tissue infections_: e.g. infected ulcers, wound
infections, abscesses,
cellulitis, otitis externa, erysipelas, infected burns.
_ _
_Bone and joint infections_: e.g. osteomyelitis, septic arthritis.
_ _
_Intra-abdominal infections_: e.g. peritonitis, intra-abdominal
abscesses.
_ _
_Infections of the biliary tract_: e.g. cholangitis, cholecystitis,
empyema of the gall
bladder.
_ _
_Gastro-intestinal infections_: e.g. enteric fever, infective
diarrhoea.
_ _
_Pelvic infections_: e.g. salpingitis, endometritis, pelvic
inflammatory disease.
_ _
_Severe systemic infections_: e.g. septicaemia, bacteraemia,
peritonitis, infections in
immuno-suppressed patients.
_ _
_Gonorrhoea_:
including
urethr